Comparison of the Clinical Outcomes Between Early and Delayed Transplantation After SARS-CoV-2Infection
10.3346/jkms.2024.39.e137
- Author:
Sang Hyun RA
1
;
A Reum KIM
;
Hyeon Mu JANG
;
Euijin CHANG
;
Seongman BAE
;
Jiwon JUNG
;
Min Jae KIM
;
Yong Pil CHONG
;
Sang-Oh LEE
;
Sang-Ho CHOI
;
Yang Soo KIM
;
Sung-Han KIM
Author Information
1. Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- Publication Type:Brief Communication
- From:Journal of Korean Medical Science
2024;39(14):e137-
- CountryRepublic of Korea
- Language:EN
-
Abstract:
Our study analyzed 95 solid organ transplant (SOT) and 78 hematopoietic stem cell transplant (HSCT) recipients with prior coronavirus disease 2019 (COVID-19). Patients who underwent transplantation within 30 days of COVID-19 infection comprised the early group, and those who underwent transplantation post-30 days of COVID-19 infection comprised the delayed group. In the early transplantation group, no patient, whether undergoing SOT and HSCT, experienced COVID-19-associated complications. In the delayed transplantation group, one patient each from SOT and HSCT experienced COVID-19-associated complications. Additionally, among early SOT and HSCT recipients, two and six patients underwent transplantation within seven days of COVID-19 diagnosis, respectively. However, no significant differences were observed in the clinical outcomes of these patients compared to those in other patients. Early transplantation following severe acute respiratory syndrome coronavirus 2 infection can be performed without increased risk of COVID-19-associated complications. Therefore, transplantation needs not be delayed by COVID-19 infection.
